$AIP

RAZA SAIYED ATIQ sold $2.5M of AIP (indirect holdings)

RAZA SAIYED ATIQ sold 70,000 indirectly-held shares of Arteris, Inc. (AIP) at an average of $36.02 ($35.99–$36.45, $2.52M total) across 2 trades on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · RAZA SAIYED ATIQ
Published Jun 3, 2026, 9:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:47 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Bearish
medium confidence
Mentioned
$AIP
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPBearishLow
01

Why it matters

The director's sale adds modest supply and may be interpreted as a negative signal.

02

Market read

Primary disclosure of an insider sell; modest materiality but new information for traders.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 5/10Novelty 6/10Timing: post‑market filing on June 3

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$AIPBearishMedium confidence
Context

Director Raza Saied Atiq sold 70,000 shares for $2.5M via a 10b5-1 plan, reducing holdings to 140,000 shares.

Expected impact

likely downward pressure as the market prices in the director's sell-off

Evidence & confidence

A $2.5M sale by a director signals potential lack of confidence and adds supply to the market.

Market effects

Minimal impact on the broader semiconductor IP sector.

No significant regional effect.

Limited to investors tracking insider activity.

Counterpoint

The sale could be a routine liquidity event unrelated to company fundamentals.

Key entities

  • Arteris, Inc.

    US‑listed semiconductor IP provider (ticker AIP).

  • Raza Saied Atiq

    Director of Arteris, Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to